Eli Lilly & Co. kicked off construction of a plant to boost the production of its wildly popular weight-loss drugs, which have yet to gain a foothold in Europe.
The factory will open in 2027 and ship worldwide, the US drugmaker said at the groundbreaking ceremony near Frankfurt on Monday.
Lilly is starting work on the plant as its weight-loss blockbuster Zepbound faces shortages in the US and the company races against Novo Nordisk A/S to supply the world with a new generation of injected obesity medicines.
Read more: https://www.bloomberg.com/news/articles/2024-04-08/lilly-s-2-5-billion-german-plant-will-boost-obesity-drug-supply?srnd=undefined&sref=omvmmwIg
--------
Subscribe to our YouTube channel: https://trib.al/KM4k5RA
Subscribe to Bloomberg Originals: https://trib.al/dJv9Uw8
Bloomberg Quicktake brings you global social video spanning business, technology, politics and culture. Make sense of the stories changing your business and your world.
Connect with us on…
YouTube: https://www.youtube.com/user/Bloomberg
Breaking News on YouTube: https://www.youtube.com/@BloombergQuicktakeNow..Eli Lilly to Boost Obesity Drug Supply With Germany Factory 9146a65c9